Company intelligence / Profile preview

Medilac

Ownership: Private
Development stage: Other

Overview

Medilac is a pharmaceutical company based in Vietnam that specializes in the distribution, marketing, and manufacturing of a wide range of healthcare products. The company focuses on providing high-quality medicines, including antibiotics, gastrointestinal treatments, and nutritional supplements, to the domestic market. Medilac operates through a robust distribution network, partnering with international pharmaceutical manufacturers to bring advanced therapeutic solutions to hospitals and pharmacies across Vietnam. In addition to distribution, the company is involved in the registration and commercialization of various pharmaceutical products and medical devices.

Therapeutic areas: Infectious DiseasesMetabolic DisordersGastroenterology
Modalities: Small moleculeVaccineBiologic
Industry: Contract Manufacturing Organization

Partnerships

Hanmi PharmaceuticalDaewon Pharmaceutical

Beyond the preview

Go deeper on Medilac.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medilac.